Literature DB >> 15312125

Presence of immunoglobulin M antibodies around the glomerular capillaries and in the mesangium of normal and passive Heymann nephritis rats.

Arpad Z Barabas1, Chad D Cole, Arpad D Barabas, Jord M Cowan, Chang Soon Yoon, David M Waisman, Rene Lafreniere.   

Abstract

Summary Diffuse distribution of small, faintly staining, beaded deposits of rat immunoglobulin M (IgM) around the glomerular capillary blood vessels, and a more intensely staining larger deposition in the mesangium, were observed on the kidney sections of normal rats. As glomerular-fixed nephritogenic antigens are known to be present on the epithelial aspect of the glomerular basement membrane (GBM), especially at the soles of foot processes and at the slit pores, it was assumed that the IgM antibodies were directed against these antigens. Investigation by immunofluorescent antibody double-staining techniques of rat kidney sections obtained from normal and rabbit anti-FX1A-injected rats stained for the nephritogenic antigen showed that a number of antigenic sites in the glomeruli and in the mesangium shared antibody hits by heterologous rabbit IgG and autologous rat IgM antibodies. Most sites in the glomeruli stained specifically for rat IgM or rabbit IgG, but preferentially for the latter. The intensely fluorescent mesangial deposits stained mainly for rat IgM, indicating that at these sites the antigenic material was virtually saturated, while areas at the entry to the mesangial space also stained for rabbit IgG, indicating that at these locations free nephritogenic epitopes were still available for reaction with the anti-FX1A antibody. Western blot analysis have shown that the rabbit anti-rat FX1A IgG and the rat anti-rat KF3 IgM antibodies are directed against the same renal tubular-derived antigen with a molecular weight of 70,000. These experimental findings collectively demonstrate that the heterologous IgG and autologous IgM antibodies are directed against the same nephritogenic antigen, which is found in the glomeruli, the mesangium and the proximal convoluted tubules. Thus, the IgM autoantibody has a possible physiological role but, in addition, there is evidence of active immunophagocytic events, manifested in a rapid and continuous entrapment and expulsion of macromolecules after their processing by the mesangial cells of normal and passive Heymann nephritis rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312125      PMCID: PMC2517517          DOI: 10.1111/j.0959-9673.2004.00395.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  56 in total

1.  Immortalized rat proximal tubule cells produce membrane bound and soluble megalin.

Authors:  F F Jung; D R Bachinsky; S S Tang; G Zheng; D Diamant; L Haveran; R T McCluskey; J R Ingelfinger
Journal:  Kidney Int       Date:  1998-02       Impact factor: 10.612

Review 2.  CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.

Authors:  P Casali; A L Notkins
Journal:  Immunol Today       Date:  1989-11

3.  Experimental glomerulonephritis.

Authors:  D J Salant; A V Cybulsky
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Formation of immune deposits and disease.

Authors:  G Andres; J R Brentjens; P R Caldwell; G Camussi; S Matsuo
Journal:  Lab Invest       Date:  1986-11       Impact factor: 5.662

5.  Auto-immune nephritis in rats.

Authors:  A Z Barabas; R Lannigan
Journal:  J Pathol       Date:  1969-03       Impact factor: 7.996

6.  Suppression of experimental membranous glomerulonephritis in rats by an anti-MHC class II antibody.

Authors:  Y Hasegawa; H Kaneoka; T Tanaka; S Ogahara; T Matsumae; R Noda; K Yoshitake; T Murata; S Naito
Journal:  Nephron       Date:  2001-07       Impact factor: 2.847

7.  Isolation and characterization of circulating immune complexes from rats with experimental membranous nephropathy.

Authors:  M T Hori; C K Abrass
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

8.  Factors influencing susceptibility of LEW rats to Heymann nephritis.

Authors:  B Noble; J B Van Liew; G A Andres; J R Brentjens
Journal:  Clin Immunol Immunopathol       Date:  1984-02

9.  Characterization of antigens and antibody specificities involved in Heymann nephritis.

Authors:  K Kamata; L G Baird; M E Erikson; A B Collins; R T McCluskey
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

10.  Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen.

Authors:  T S Edgington; R J Glassock; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  6 in total

1.  Production of heterologous IgG antibody against Heymann nephritis antigen by injections of immune complexes.

Authors:  Arpad Z Barabas; Chad D Cole; Maria Sensen; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2011-11-22       Impact factor: 1.925

Review 2.  Regaining tolerance to a self-antigen by the modified vaccination technique.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere; Donald Mackay Weir
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

3.  Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-12       Impact factor: 1.925

4.  Tolerance, loss of tolerance and regaining tolerance to self by immune-mediated events.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Richard Milton Graeff; Rene Lafreniere; Donald Mackay Weir
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

5.  Production of Heymann nephritis by a chemically modified renal antigen.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

6.  Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Biologics       Date:  2007-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.